• Vision loss from OZEMPIC & WEGOVY, with Joseph Rizzo, M.D.

  • Jul 6 2024
  • Length: 40 mins
  • Podcast

Vision loss from OZEMPIC & WEGOVY, with Joseph Rizzo, M.D. By cover art

Vision loss from OZEMPIC & WEGOVY, with Joseph Rizzo, M.D.

Listen for free

View show details

  • Summary

  • DoctorPodcasts EPISODE #59: #OZEMPIC #WEGOVY #semaglutides are associated with severe, acute, irreversible vision loss from optic nerve damage in 7/3/24 article http://jamanetwork.com/journals/jamaophthalmology/article-abstract/2820255. Watch this video interview of article author, Harvard neuro-ophthalmologist Joseph Rizzo, MD, http://eye.hms.harvard.edu/josephrizzo explain the study findings. Dr. Rizzo found that diabetics who were using Ozempic or Wegovy had 4 times the risk of vision loss as compared to diabetics who were not using these drugs. Obese people who were using Ozempic or Wegovy had a 7 times the risk of vision loss than obese people who weren't using these drugs. The vision loss was from a condition known as "Non-arteritic ischemic anterior optic neuropathy" which is damage to the optic nerve that connects the eye and brain.

    Show more Show less
activate_primeday_promo_in_buybox_DT
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about Vision loss from OZEMPIC & WEGOVY, with Joseph Rizzo, M.D.

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available